On 9.12.10 an english cardiologist expressed concerns at the significant amount of strokes that occured during the BTT trials.On 10.12.10 Heartware announces a public offering and Appletree Partners intention to sell 1000000 shares.Is the problem larger than reported and prompted Heartwares early capitol raising and for Appletree to redeem its initial investment.Say it isnt so.
Add to My Watchlist
What is My Watchlist?